Haematologica, Vol 92, Issue 9, 1264-1265 doi:10.3324/haematol.11383
Copyright © 2007 by Ferrata Storti Foundation

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Lahr, G. Articles by Kohne, E. Search for Related Content PubMed PubMed Citation Articles by Lahr, G. Articles by Kohne, E.

Red Cell Disorders

Codon 104(-G), a dominant ß⁰-thalassemia-like phenotype in a German Caucasian family is associated with mild chronic hemolytic anemia but influenced in severity by co-inherited genetic factors

Georgia Lahr, Joaquin Brintrup, Stefan Over, Gerhard E. Feurle, Klaus-Michel Debatin, Elisabeth Kohne

Department of Pediatrics, University Children's Hospital, Ulm, Germany (GL, JB, K-MD, EK); DRK-Krankenhaus Neuwied, Neuwied, Germany (SO, GWF)

Correspondence: Georgia Lahr, Department of Pediatrics, University Children’s Hospital, Eythstrasse 24, D-89075 Ulm, Germany. Phone: international +49.731.50057234. Fax: international +49.731.50057235. E-mail: georgia.lahr{at}uni-ulm.de

TOP ABSTRACT References

 
Codon 104(–G), a heterozygous frameshift mutation in exon 2 of HBB, resulted in a dominantly inherited ß⁰-phenotype with mild anemia in a German kindred, and thalassemia intermedia in the index patient. A co-inherited gene triplication, long-term transfusion therapy, and ineffective erythropoiesis were confounding factors.

Key words: dominant ß⁰-thalassemia, triplication.

We report a ß⁰-thalassemia deletion mutation with dominant mode of inheritance in a German Caucasian family of Huguenot descent (Figure 1). The proposita (IV-5) presented in our hospital (2002) with hepatosplenomegaly and a Thalassemia intermedia phenotype. Erythrocytes had been previously transfused to her (300 units) and her brother (IV-2, 500 units). Her brother died of malignant melanoma in 2003. Transfusion therapy was continued in the proposita up to the time, when iron overload became evident. From 1999, she had been treated with erythropoietin and iron chelation therapy. Her sister (IV-7) and daughter (V-4) presented with mild chronic hemolytic anemia. Elevated HbA₂ (3.9–5.1%) and HbF-levels (3.8 and 5.1%) in the proposita and her daughter (V-4) were detected by high performance liquid chromatography on an ÄKTA^Tm basic 10A system (Amersham Biosciences, Freiburg). Low values for Hb (7.7–11.2 g/dL), Hct (28–35%), MCV (69–73.2 fl) and MCH (22.1–24.2 pg) indicated hypochromic anemia (Table 1). Erythrocyte enzyme activities for glycolysis and pentose phosphate cycle were normal. Elevated serum concentrations of iron (39.3 µmol/L), ferritin (2016 µg/L) and a transferrin saturation of 89.8% denoted iron overload and/or hemochromatosis in the proposita. Ultrasonography and computerized tomography showed increased hepatic density, a clinical sign of iron overload. The absence of aberrant or unstable hemoglobin fraction in biochemical Hb analyses together with a thalassemia-like clinical picture suggested ß⁰-thalassemia. Informed consent was given for genetic analyses. DNA extraction and polymerase chain reaction (PCR) analysis were performed using standard methods, sequencing with a CEQ Quick Start Kit on a CEQ 8800 automated DNA Sequencer (Beckman Coulter, Krefeld). Primers and PCR conditions are available from the authors upon request. The family members were heterozygous for a ß-thalassemia mutation [codon 104(–G)] at the exon2/IVS-II boundary within a homonucleotide run of three guanines (494–496; –G) (Figure 2A). The deletion mutant at the end of exon 2 was similar to the dominant ß0-deletion mutant Hb Manhattan [codon 109(–G)] at the beginning of exon 3.¹ Both mutation-dependent modified C-terminal sequences extend to 156 amino acids and include an identical 48-residue-long terminal tail sequence from codon 109 up to codon 156. The –1 frameshift led to the introduction of hydrophobic residues and five additional prolines, which compromise the formation of a normal H-helix. The unstable polypeptide was not detectable, probably due to rapid metabolization.¹ Mutant ß globin mRNA, and erythrocyte inclusion bodies were also undetectable. Coexistence of a triplicated gene enhances globin chain imbalance and may be associated with more severe ß-thalassemia features.^2,3 globin gene amplification in the proposita was detected by MLPA-analysis (seen as an increase in the 2-peak), using the MLPA -globin kit (ServiceXS; http://www.servicexs.com) with adapted fluorescent oligonucleotides and the CEQ 8800 DNA Sequencer (Figure 2B). Deposition of excessive chains in erythroid precursors in the bone marrow may have led to accelerated apoptosis and ineffective erythropoiesis.^4,5 Anemia and ongoing hemolysis (elevated serum concentrations of unconjugated bilirubin and lactate dehydrogenase and a suppressed level of haptoglobin) in the presence of only a moderate reticulocytosis (2.1%) suggest an impeded erythropoiesis. A bilirubin UDP-glucuronosyltransferase 1A1 (UGT1A1) promoter polymorphism may be associated both with an unconjugated bilirubin level and an elevated risk of cholelithiasis. The TA repeats (5, 6, 7, or 8) in the TATA box are inversely correlated with gene transcription efficiency and overall enzyme activity.⁶ Indeed, the proposita and her sister (IV-7), who were both cholecystectomized, displayed a (TA)₆/(TA)₇ genotype. The (TA)₅/(TA)₆ genotype of the daughter (V-4) was associated with normal bilirubin concentrations and a stone-free gallbladder.⁷ The polymorphic single-base substitution –158 ^G (CT; XmnI polymorphism) appears to cause an increase of HbF especially during erythropoietic stress, partially compensating for absent ß-chain synthesis with consequent amelioration of globin chain imbalance and a milder phenotype.^8,9 However, since, despite heterozygosity in three family members, elevated HbF-values (3.8 and 5.1%) were only detected in the proposita and her daughter this remains open to debate (V-4; Table 1). Co-inheritance of a heterozygous H63D mutation in the hereditary hemochromatosis (HFE) gene may contribute to severe iron overload in ß-thalassemia minor.¹⁰ However, the presence of a heterozygous H63D mutation in three family members, but iron overload only in the proposita who had received multiple blood transfusions, indicates that it was mainly blood transfusion therapy along with ineffective erythropoiesis that caused secondary hemochromatosis.

View larger version (19K): [in this window] [in a new window] [Download PPT slide]

Figure 1. Pedigree of German kindred shows segregation of dominantly transmitted ß-Thalassemia. The proposita is marked by an arrow; : dead; : dominant Thalassemia; : healthy; : heterozygous; ?: unconfirmed disease.

View this table: [in this window] [in a new window] [Download PPT slide]

Table 1. Hematological data of four members of German index family (after discontinued transfusion therapy of members IV-2 and IV-5).

View larger version (32K): [in this window] [in a new window] [Download PPT slide]

Figure 2. ß- and globin gene analyses. A. Sequence analysis of the PCR-amplified exon2/3’end-region of ß globin. Above the electropherogram a schematic drawing of exon/intron composition is shown. Genomic DNA from proposita shows a heterozygous G deletion at the end of exon 2 (exon2/IVS-II splice site). B. Peak profiles of HBA gene cluster MLPA-analysis. Left panel: a triplicated 2-peak ( ) is present in the proposita (IV-5). Right panel: a wild type 2-peak ( ) is present in her daughter (V-4); [*] internal size marker; 2-peaks are indicated by an arrow.

 
we thank Marianne Krause (Department of Pediatrics, University Children's Hospital, Ulm) for her technical assistance, PD. Dr. Dagmar Kunz (Zentrallabor, DRK Krankenhaus Neuwied) for his advice and blood analyses, and Dr. Roswitha Dickerhoff (Kinderklinik St. Augustin) for her guidance

TOP ABSTRACT References

 

1. Kazazian HH Jr, Dowling CE, Hurwitz RL, Coleman M, Stopeck A, Adams JG 3rd. Dominant thalassemia-like phenotypes associated with mutations in exon 3 of the ß-globin gene. Blood 1992;79:3014-8.[Abstract/Free Full Text]
2. Kimura EM, Grignoli CR, Pinheiro VR, Costa FF, Sonati MF. Thalassemia intermedia as a result of heterozygosis for ß⁰-thalassemia and ^{anti-3, 7} genotype in a Brazilian patient. Braz J Med Biol Res 2003;36:699-701.[Web of Science][Medline]
3. Thein SL. Is it dominantly inherited ß thalassaemia or just a ß-chain variant that is highly unstable? Br J Haematol 1999;107:12-21.[CrossRef][Web of Science][Medline]
4. Pootrakul P, Sirankapracha P, Hemsorach S, Moungsub W, Kumbunlue R, Piangitjagum A, et al. A correlation of erythrokinetics, ineffective erythropoiesis, and erythroid precursor apoptosis in thai patients with thalassemia. Blood 2000;96:2606-12.[Abstract/Free Full Text]
5. Schrier SL. Pathophysiology of thalassemia. Curr Opin Hematol 2002;9:123-6.[CrossRef][Web of Science][Medline]
6. Beutler E, Gelbart T, Demina A. Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism? Proc Natl Acad Sci USA 1998;95:8170-4.[Abstract/Free Full Text]
7. Chaar V, Keclard L, Diara JP, Leturdu C, Elion J, Krishnamoorthy R, et al. Association of UGT1A1 polymorphism with prevalence and age at onset of cholelithiasis in sickle cell anemia. Haematologica 2005;90:188-99.[Abstract/Free Full Text]
8. Mastropietro F, Modiano G, Cappabianca M, Foglietta E, D'Asero C, Mezzabotta M, et al. Factors regulating Hb F synthesis in thalassemic diseases. BMC Blood Disord 2002;2:2.[CrossRef][Medline]
9. Galanello R, Cao A. Relationship between genotype and phenotype. Thalassemia intermedia. Ann N Y Acad Sci 1998;850:325-33.[CrossRef][Web of Science][Medline]
10. Ruiz-Arguelles GJ, Garces-Eisele J, Reyes-Nunez V, Sanchez-Anzaldo J, Ruiz- Delgado GJ, Jimenez-Gonzalez C, et al. Heterozygosity for the H63D mutation in the hereditary haemochromatosis (HFE) gene may lead into severe iron overload in ß-thalassemia minor: observations in a thalassemic kindred. Rev Invest Clin 2001;53:117-20.[Web of Science][Medline]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Lahr, G. Articles by Kohne, E. Search for Related Content PubMed PubMed Citation Articles by Lahr, G. Articles by Kohne, E.